Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods

Journal of Perinatal Medicine

Volumn 38, Issue 5, 2010, Pages 503-513

  Digiulio, Daniel B ^a,b   Gervasi, Mariateresa ^c   Romero, Roberto ^d,e   Mazaki Tovi, Shali ^d,e   Vaisbuch, Edi ^d,e   Kusanovic, Juan Pedro ^d,e   Seok, Kimberley S ^b   Gómez, Ricardo ^f,g   Mittal, Pooja ^d,e   Gotsch, Francesca ^d   Chaiworapongsa, Tinnakorn ^d,e   Oyarzún, Enrique ^g   Kim, Chong Jai ^d,e   Relman, David A ^a,b,h  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h STANFORD UNIVERSITY   (United States)

Author keywords

16S rRNA; IL 6; intra amniotic infection; intra amniotic inflammation; PCR; preeclampsia; pregnancy; Sneathia Leptotrichia spp.; Ureaplasma urealyticum

Indexed keywords

GLUCOSE; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE; RIBOSOME DNA;

ADULT; AMNION FLUID; ARTICLE; BACTERIAL GENE; BLOOD CELL COUNT; CORYNEBACTERIUM; FEMALE; FUNGAL GENE; GENE SEQUENCE; HUMAN; INFLAMMATION; LACTOBACILLUS; LEPTOTRICHIA; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; NONHUMAN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; STREPTOCOCCUS ANGINOSUS; UREAPLASMA UREALYTICUM;

ADULT; AMNION; AMNIOTIC FLUID; BASE SEQUENCE; CHORIOAMNIONITIS; COHORT STUDIES; DNA PRIMERS; DNA, ARCHAEAL; DNA, BACTERIAL; DNA, FUNGAL; FEMALE; HUMANS; INFANT, NEWBORN; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 8; MICROBIOLOGICAL TECHNIQUES; POLYMERASE CHAIN REACTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956471325     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.078     Document Type: Article

References (146)

1. ACOG practice bulletin. Diagnosis and management of pre-eclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol. 2002;99:159-167
2. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005;43:5721-5732
3. Adriaens LM, Alessandri R, Sporri S, Lang NP, Persson GR. Does pregnancy have an impact on the subgingival micro-biota? J Periodontol. 2009;80:72-81.
4. AggarWal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 2006;69:621-624
5. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215: 403-410
6. Arriaga-Pizano L, Jimenez-Zamudio L, Vadillo-Ortega F, Martinez-Flores A, Herrerias-Canedo T, Hernandez-Guerrero C. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the cho-riodecidual and fetal compartments. J Soc Gynecol Investig. 2005;12:335-342
7. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN, et al. Neutrophil CD11B expression and neutrophil activation in pre-eclampsia. Clin Sci (Lond). 1997;92:37-44.
8. Barton JR, Sibai BM. Diagnosis and management of hemo-lysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol. 2004;31:807-33, vii.
9. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J. 1999;138:S528-33.
10. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab. 2001; 86:2505-2512
11. Boennelycke M, Christensen JJ, Arpi M, Krause S. Lepto-trichia amnionii found in septic abortion in Denmark. Scand J Infect Dis. 2007;39:382-383
12. Borst A, Box AT, Fluit AC. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis. 2004;23:289-299
13. Bretelle F, Sabatier F, Blann A, D'Ercole C, Boutiere B, Mutin M, et al. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses: comparison with pre-eclampsia. Br J Obstet Gynaecol. 2001; 108:1277-1282
14. Brinig MM, Lepp PW, Ouverney CC, Armitage GC, Relman DA. Prevalence of bacteria of division TM7 in human sub-gingival plaque and their association with disease. Appl Environ Microbiol. 2003;69:1687-1694
15. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu. 1972;1:177-191
16. Bujold E, Morency AM, Rallu F, Ferland S, Tetu A, Duper-ron L, et al. Bacteriology of amniotic fluid in women with suspected cervical insufficiency. J Obstet Gynaecol Can. 2008;30:882-887
17. Bujold E, Romero R, Chaiworapongsa T, Kim YM, Kim GJ, Kim MR, et al. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in pre-eclampsia has a uterine origin. J Matern Fetal Neonatal Med. 2005;18:9-16.
18. Chaiworapongsa T, Gervasi MT, Refuerzo J, Espinoza J, Yoshimatsu J, Berman S, et al. Maternal lymphocyte sub-populations (CD45RAq and CD45ROq) in preeclampsia. Am J Obstet Gynecol. 2002;187:889-893
19. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004;190:1541-1547
20. Chaiworapongsa T, Romero R, Gotsch F, Espinoza J, Nien JK, Goncalves L, et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in pre-eclampsia and small for gestational age. J Matern Fetal Neonatal Med. 2008;21:41-52.
21. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005;17:3-18.
22. Chen LJ, Gao H, Zhou H, Zou L, Zou P. Contribution of interferon-gamma receptor 1 gene polymorphisms to pre-eclampsia in China. Am J Reprod Immunol. 2010;63:331-338
23. Clark BA, Halvorson L, Sachs B, Epstein FH. Plasma endo-thelin levels in preeclampsia: elevation and correlation with uric acid levels and renal impairment. Am J Obstet Gynecol. 1992;166:962-968
24. Collins MD, Hoyles L, Tornqvist E, von Essen R, Falsen E. Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov. Syst Appl Microbiol. 2001;24:358-361
25. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 1998;40:102-111
26. Crispi F, Dominguez C, Llurba E, Martin-Gallan P, Cabero L, Gratacos E. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 2006;195:201-207
27. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Fait G, Wol-man I, et al. Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol. 1998;39:376-380
28. Davidge ST. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol. 1998; 16:65-73.
29. De Martino SJ, Mahoudeau I, Brettes JP, Piemont Y, Mon-teil H, Jaulhac B. Peripartum bacteremias due to Leptotri-chia amnionii and Sneathia sanguinegens, rare causes of fever during and after delivery. J Clin Microbiol. 2004;42: 5940-5943
30. Dekker GA, Sibai BM. Etiology and pathogenesis of pre-eclampsia: current concepts. Am J Obstet Gynecol. 1998; 179:1359-1375
31. DeLong EF. Archaea in coastal marine environments. Proc Natl Acad Sci USA. 1992;89:5685-5689
32. Di Renzo GC. The great obstetrical syndromes. J Matern Fetal Neonatal Med. 2009;22:633-635
33. Di Giulio DB, Romero R, Amogan HP, Kusanovic JP, Bik EM, Gotsch F, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One. 2008;3: e3056.
34. Di Giulio DB, Romero R, Kusanovic JP, Gomez R, Kim CJ, Seok K, et al. Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and fetal outcome in women with preterm prelabor rupture of membranes. Am J Reprod Immunol. 2010;PMID 20331587.
35. Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M. Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. J Reprod Immunol. 1996;31:97-107.
36. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal micro-bial flora. Science. 2005;308:1635-1638
37. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med. 2008;21:279-287
38. Espinoza J, Nien JK, Kusanovic JP, Goncalves LF, Medina LH, Gomez R, et al. The combined use of uterine artery Doppler and maternal plasma placental growth factor concentrations identifies patients at risk for early onset and/or severe preeclampsia. Ultrasound Obstet Gynecol. 2006;28: 387-388
39. Espinoza J, Romero R, Mee KY, Kusanovic JP, Hassan S, Erez O, et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med. 2006;34: 447-458
40. Espinoza J, Romero R, Nien JK, Kusanovic JP, Richani K, Gomez R, et al. A role of the anti-angiogenic factor s-VEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome). J Matern Fetal Neonatal Med. 2006;19:607-613
41. Faas MM, Broekema M, Moes H, van der SG, Heineman MJ, de Vos P. Altered monocyte function in experimental preeclampsia in the rat. Am J Obstet Gynecol. 2004;191: 1192-1198
42. Faas MM, Schuiling GA, Baller JF, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol. 1994;171:158-164
43. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353:1899-1911
44. Gardella C, Riley DE, Hitti J, Agnew K, Krieger JN, Eschenbach D. Identification and sequencing of bacterial rDNAs in culture-negative amniotic fluid from women in premature labor. Am J Perinatol. 2004;21:319-323
45. Gervasi MT, Chaiworapongsa T, Pacora P, Naccasha N, Yoon BH, Maymon E, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol. 2001;185:792-797
46. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev. 2002;8:3-13.
47. Gotsch F, Romero R, Kusanovic JP, Chaiworapongsa T, Dombrowski M, Erez O, et al. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. J Matern Fetal Neonatal Med. 2008;21:389-402.
48. Haller H, Ziegler EM, Homuth V, Drab M, Eichhorn J, Nagy Z, et al. Endothelial adhesion molecules and leukocyte inte-grins in preeclamptic patients. Hypertension. 1997;29:291-296
49. Hanff PA, Rosol-Donoghue JA, Spiegel CA, Wilson KH, Moore LH. Leptotrichia sanguinegens sp. nov., a new agent of postpartum and neonatal bacteremia. Clin Infect Dis. 1995;20(Suppl 2):S237-9.
50. Hassan S, Romero R, Hendler I, Gomez R, Khalek N, Espi-noza J, et al. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med. 2006;34:13-19
51. Higgins JR, Papayianni A, Brady HR, Darling MR, Walshe JJ. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol. 1998;179:464-469
52. Hnat MD, Meadows JW, Brockman DE, Pitzer B, Lyall F, Myatt L. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol. 2005;193:836-840
53. Kanayama N, She L, Maehara K, Kajiwara Y, Terao T. Induction of HELLP syndrome-like biochemical parameters by stimulation of the celiac ganglion in rats. J Hypertens. 1996;14:453-459
54. Ke D, Menard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, et al. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000;46:324-331
55. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93: 1049-1059
56. Kim MJ, Romero R, Gervasi MT, Kim JS, Yoo W, Lee DC, et al. Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amni-otic infection. Lab Invest. 2009;89:924-936
57. Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with pre-eclampsia. J Clin Endocrinol Metab. 2003;88:2348-2351
58. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol. 1993;169:160-165
59. Krauss T, Pauer HU, Augustin HG. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy. 2004;23:101-111
60. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 1997;38:302-306
61. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclamp-sia. J Matern Fetal Neonatal Med. 2009;22:1021-1038
62. Kusanovic JP, Romero R, Hassan SS, Gotsch F, Edwin S, Chaiworapongsa T, et al. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclamp-sia and small for gestational age pregnancies. J Matern Fetal Neonatal Med. 2007;20:867-878
63. Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA. Methanogenic archaea and human perio-dontal disease. Proc Natl Acad Sci USA. 2004;101:6176-6181
64. Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 2005;48:372-386
65. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.
66. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med. 2004;350:672-683
67. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karu-manchi SA. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol. 2006;194:1034-1041
68. Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, et al. Urinary placental growth factor and risk of preeclamp-sia. J Am Med Assoc. 2005;293:77-85.
69. Lindheimer MD. Hypertension in pregnancy. Hypertension. 1993;22:127-137
70. Lindheimer MD, Romero R. Emerging roles of antiangio-genic and angiogenic proteins in pathogenesis and prediction of preeclampsia. Hypertension. 2007;50:35-36
71. Liu LP, Huang W, Lu YC, Liao AH. Enhanced maternal anti-fetal immunity contributes to the severity of hypertensive disorder complicating pregnancy. Am J Reprod Immunol. 2010; wEpub ahead of printx.
72. Lok CA, Jebbink J, Nieuwland R, Faas MM, Boer K, Sturk A, et al. Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia. Am J Reprod Immunol. 2009;61:346-359
73. Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 1997;104:223-228
74. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533-538
75. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111:649-658
76. Mazaki-Tovi S, Romero R, Kim SK, Vaisbuch E, Kusanovic JP, Erez O, et al. Could alterations in maternal plasma vis-fatin concentration participate in the phenotype definition of preeclampsia and SGA? J Matern Fetal Neonatal Med. 2009;PMID:19900033.
77. Mazaki-Tovi S, Romero R, Vaisbuch E, Kusanovic JP, Erez O, Gotsch F, et al. Maternal serum adiponectin multimers in preeclampsia. J Perinat Med. 2009;37:349-363
78. McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ, McClure N. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 2004;191:1240-1246
79. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol. 1994;98:110-114
80. Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria. BMC Infect Dis. 2009;9:89.
81. Mittendorf R, Lain KY, Williams MA, Walker CK. Pre-eclampsia. A nested, case-control study of risk factors and their interactions. J Reprod Med. 1996;41:491-496
82. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369-382
83. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer IA, Lyall F. Differential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, pre-eclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem. 1997;45:1433-1438 (Pubitemid 27402804)
84. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and pre-eclampsia. Am J Obstet Gynecol. 2006;195:40-49
85. Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in pre-eclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188:264-268
86. Nien JK, Yoon BH, Espinoza J, Kusanovic JP, Erez O, Soto E, et al. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol. 2006;195: 1025-1030
87. Obata NH, Kurauchi O, Kikkawa F, Yamada M, Fukuda Y, Itakura A. Preeclampsia with fetal death in a patient with schistosomiasis japonica. Arch Gynecol Obstet. 1998;261: 101-104
88. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11:18-25.
89. Palmer C, Bik EM, Di Giulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177.
90. Poston L, Chappell LC. Is oxidative stress involved in the aetiology of pre-eclampsia? Acta Paediatr Suppl. 2001;90: 3-5.
91. Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 2005;26:563-573
92. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6:435-448
93. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499-506.
94. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21:597-602.
95. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594
96. Relman D, Loutit J, Schmidt T, Falkow S, Tompkins L. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N Engl J Med. 1990;323: 1573-1580
97. Rizzo R, Andersen AS, Lassen MR, Sorensen HC, Bergholt T, Larsen MH, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol. 2009;62:320-338
98. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161:1200-1204
99. Robinson CJ, Johnson DD, Chang EY, Armstrong DM, Wang W. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 2006;195:255-259
100. Romero R. The child is the father of the man. Prenat Neonat Med. 1996;1:8-11.
101. Romero R. Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med. 2009;22:636-639
102. Romero R, Emamian M, Quintero R, Wan M, Hobbins JC, Mazor M, et al. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol. 1988;159:114-119
103. Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, et al. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol. 1992;167:1086-1091
104. Romero R, Mazor M, Morretti R, Avila C, Oyarzun E, Insunza A, et al. Infection and labor. VII: Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol. 1992;166:129-133.
105. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23.
106. Romero R, Nores J, Mazor M, Sepulveda W, Oyarzun E, Parra M, et al. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance. J Reprod Med. 1993;38:543-548
107. Romero R, Quintero R, Nores J, Avila C, Mazor M, Hanao-ka S, et al. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amni-otic cavity and predict preterm delivery. Am J Obstet Gyne-col. 1991;165:821-830
108. Roy KK, Malhotra N, Banerjee K. Recurrent eclampsia in a woman with chronic pyelonephritis. Eur J Obstet Gynecol Reprod Biol. 2001;94:307-308
109. Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol. 1998;179:80-86
110. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with pre-eclampsia. Am J Reprod Immunol. 1999;41:297-306.
111. Sakawi Y, Tarpey M, Chen YF, Calhoun DA, Connor MG, Chestnut DH, et al. Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclamp-sia. Anesthesiology. 2000;93:1446-1455
112. Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M, et al. Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol. 1992;166:624-628
113. Schwartz DN, Schable B, Tenover FC, Miller RA. Lepto-trichia buccalis bacteremia in patients treated in a single bone marrow transplant unit. Clin Infect Dis. 1995;20:762-767
114. Seely EW. Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. J Clin Endo-crinol Metab. 1999;84:1858-1861
115. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90:4895-4903
116. Shukla SK, Meier PR, Mitchell PD, Frank DN, Reed KD. Leptotrichia amnionii sp. nov., a novel bacterium isolated from the amniotic fluid of a woman after intrauterine fetal demise. J Clin Microbiol. 2002;40:3346-3349
117. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799
118. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 1995;172:642-648
119. Singh A, Sharma D, Raghunandan C, Bhattacharjee J. Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia. Am J Reprod Immunol. 2010;63:244-251
120. Soto E, Romero R, Richani K, Espinoza J, Chaiworapongsa T, Nien JK, et al. Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. J Matern Fetal Neonatal Med. 2009; wEpub ahead of printx.
121. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyro-sine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2005;122: 33-39
122. Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med. 2006; 354:1857-1858
123. Sunder-Plassmann G, Derfler K, WAgner L, Stockenhuber F, Endler M, Nowotny C, et al. Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimmun. 1989;2:203-205
124. Tamrakar R, Yamada T, Furuta I, Cho K, MorikaWA M, Yamada H, et al. Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vagi-nosis scores in pregnant Japanese women. BMC Infect Dis. 2007;7:128.
125. Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol. 1998; 16:17-31.
126. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet. 2001;75:243-249
127. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for pre-eclampsia. J Clin Endocrinol Metab. 2004;89:770-775
128. Than NG, Erez O, Wildman DE, Tarca AL, Edwin SS, Abbas A, et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neonatal Med. 2008;21:429-442
129. Than NG, Romero R, Erez O, Kusanovic JP, Tarca AL, Edwin SS, et al. A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. Am J Reprod Immunol. 2008;60:333-345
130. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol. 2001;184:1267-1272
131. Toft JH, Lian IA, Tarca AL, Erez O, Espinoza J, Eide IP, et al. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J Matern Fetal Neonatal Med. 2008;21:267-273
132. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Pre-eclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 1998;179:1539-1544
133. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, et al. Overexpression of the soluble vascular endo-thelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555-5563
134. Vaisbuch E, Romero R, Mazaki-Tovi S, Erez O, Kim SK, Chaiworapongsa T, et al. Retinol binding protein 4-a novel association with early-onset preeclampsia. J Perinat Med. 2010;38:129-139
135. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, et al. Soluble endoglin contributes to the patho-genesis of preeclampsia. Nat Med. 2006;12:642-649
136. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'a-qeel H, et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol. 2006;194:921-931
137. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclamp-sia. Br J Obstet Gynaecol. 1995;102:20-25
138. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998;19:581-586
139. Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zing-heim RW, O'Reilly GC, et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 1999;149:323-329
140. Wilson J, Walthert SE, Gillett WR. Strongyloides stercoralis and severe pre-eclampsia. NZ Med J. 1998;111:83.
141. Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple's-disease-associated bacterium. Lancet. 1991;338:474-475
142. Xie F, Turvey SE, Williams MA, Mor G, von Dadelszen P. Toll-like receptor signaling and pre-eclampsia. Am J Reprod Immunol. 2010;63:7-16.
143. Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, et al. Clinical implications of detection of ureaplasma urealy-ticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol. 2000;183:1130-1137
144. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, et al. The clinical significance of detecting ureaplasma urea-lyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol. 2003;189:919-924
145. Zariffard MR, Saifuddin M, Sha BE, Spear GT. Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominis. FEMS Immunol Med Microbiol. 2002;34:277-281
146. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Kar-panen T, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405-1423